Zubiaur, P.; Fernández-Campos, P.; Navares-Gómez, M.; Soria-Chacartegui, P.; Villapalos-GarcÃa, G.; Román, M.; MejÃa-Abril, G.; Ochoa, D.; Abad-Santos, F.
Variants in COMT, CYP3A5, CYP2B6, and ABCG2 Alter Quetiapine Pharmacokinetics. Pharmaceutics 2021, 13, 1573.
https://doi.org/10.3390/pharmaceutics13101573
AMA Style
Zubiaur P, Fernández-Campos P, Navares-Gómez M, Soria-Chacartegui P, Villapalos-GarcÃa G, Román M, MejÃa-Abril G, Ochoa D, Abad-Santos F.
Variants in COMT, CYP3A5, CYP2B6, and ABCG2 Alter Quetiapine Pharmacokinetics. Pharmaceutics. 2021; 13(10):1573.
https://doi.org/10.3390/pharmaceutics13101573
Chicago/Turabian Style
Zubiaur, Pablo, Paula Fernández-Campos, Marcos Navares-Gómez, Paula Soria-Chacartegui, Gonzalo Villapalos-GarcÃa, Manuel Román, Gina MejÃa-Abril, Dolores Ochoa, and Francisco Abad-Santos.
2021. "Variants in COMT, CYP3A5, CYP2B6, and ABCG2 Alter Quetiapine Pharmacokinetics" Pharmaceutics 13, no. 10: 1573.
https://doi.org/10.3390/pharmaceutics13101573
APA Style
Zubiaur, P., Fernández-Campos, P., Navares-Gómez, M., Soria-Chacartegui, P., Villapalos-GarcÃa, G., Román, M., MejÃa-Abril, G., Ochoa, D., & Abad-Santos, F.
(2021). Variants in COMT, CYP3A5, CYP2B6, and ABCG2 Alter Quetiapine Pharmacokinetics. Pharmaceutics, 13(10), 1573.
https://doi.org/10.3390/pharmaceutics13101573